Superimposed acute hepatitis E infection in patients with chronic liver disease.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 15176535)

Published in Indian J Gastroenterol on June 04, 2004

Authors

Rainish Monga1, Sanjay Garg, Pankaj Tyagi, Nirmal Kumar

Author Affiliations

1: Department of Gastroenterology, G B Pant Hospital, New Delhi 110 002.

Associated clinical trials:

Acute Viral Hepatitis and Diabetes Mellitus | NCT00689546

Articles citing this

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16

Hepatitis E: Epidemiology and prevention. World J Hepatol (2011) 1.01

Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection. J Clin Exp Hepatol (2013) 0.98

RNA-seq based transcriptome analysis of hepatitis E virus (HEV) and hepatitis B virus (HBV) replicon transfected Huh-7 cells. PLoS One (2014) 0.91

Hepatitis E: a complex and global disease. Emerg Health Threats J (2008) 0.89

The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus? Clin Infect Dis (2008) 0.88

HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh. J Health Popul Nutr (2009) 0.87

Hepatitis E- Is it a risk to transfusion safety? Asian J Transfus Sci (2013) 0.85

Hepatitis E and Acute-on-Chronic Liver Failure. J Clin Exp Hepatol (2013) 0.82

Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients. EBioMedicine (2015) 0.80

Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience". J Clin Exp Hepatol (2015) 0.80

Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. World J Gastroenterol (2014) 0.78

Hepatitis E virus and acute-on-chronic liver failure. Indian J Gastroenterol (2004) 0.75

Articles by these authors

Spleen stiffness in patients with cirrhosis in predicting esophageal varices. Am J Gastroenterol (2013) 3.39

Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today (2002) 2.32

Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation. Genome Res (2006) 2.12

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet (2006) 2.10

Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol (2005) 1.63

Herbal medicines for sexually transmitted diseases and AIDS. J Ethnopharmacol (2002) 1.63

Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm (2003) 1.61

Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release (2002) 1.40

Death of twins after intravenous varicella zoster immunoglobulin. Ann Pharmacother (2004) 1.37

Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J Immunol (2011) 1.35

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2004) 1.33

Quality, safety and efficacy in the 'off-label' use of medicines. Curr Drug Saf (2007) 1.28

Electrochemically controlled drug delivery based on intrinsically conducting polymers. J Control Release (2010) 1.22

Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur J Pharm Biopharm (2004) 1.21

Microbicide delivery: formulation technologies and strategies. Curr Opin HIV AIDS (2008) 1.16

A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis (2008) 1.13

Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int J Pharm (2003) 1.12

Endoscopic management of postoperative bile leaks. Hepatobiliary Pancreat Dis Int (2006) 1.10

Primary isolated extramedullary plasmacytoma of colon. World J Surg Oncol (2007) 1.09

Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. Int J Pharm (2008) 1.03

Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anticancer Drugs (2011) 0.98

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Adv Drug Deliv Rev (2009) 0.97

Permeability issues in nasal drug delivery. Drug Discov Today (2002) 0.95

Pseudoaneurysm of the inferior phrenic artery presenting as an upper gastrointestinal bleed by directly rupturing into the stomach in a patient with chronic pancreatitis. Ann Vasc Surg (2012) 0.95

A validated high performance liquid chromatographic method for analysis of nicotine in pure form and from formulations. J Pharm Biomed Anal (2003) 0.94

Surgical management of obstructive gastroduodenal tuberculosis. Trop Gastroenterol (2003) 0.94

Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. J Pharm Biomed Anal (2004) 0.94

A distal regulatory region is required for constitutive and IFN-beta-induced expression of murine TLR9 gene. J Immunol (2005) 0.93

Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. J Control Release (2005) 0.93

Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology (2009) 0.92

Crystal modifications and dissolution rate of piroxicam. Acta Pharm (2011) 0.90

Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci (2012) 0.90

Therapeutic plasma exchange in hyperlipidemic pancreatitis. Transfusion (2012) 0.90

Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J Pharm Biomed Anal (2005) 0.90

Spectrum of atypical celiac disease in North Indian children. Indian Pediatr (2004) 0.89

p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett (2005) 0.89

Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int J Pharm (2008) 0.88

Evaluation of policies to support drug development in New Zealand. Health Policy (2010) 0.88

Prone versus supine position in mechanically ventilated children: a pilot study. Med Sci Monit (2005) 0.87

Assemblies for in vitro measurement of bioadhesive strength and retention characteristics in simulated vaginal environment. Drug Dev Ind Pharm (2002) 0.86

Trypanosoma lewisi or T. lewisi-like infection in a 37-day-old Indian infant. Am J Trop Med Hyg (2011) 0.86

Lectindb: a plant lectin database. Glycobiology (2006) 0.86

Colour Doppler flow imaging findings in portal biliopathy. Trop Gastroenterol (2004) 0.85

Isolated tuberculosis of the pancreas: a report of two cases and review of the literature. Trop Gastroenterol (2003) 0.85

Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis. Indian J Gastroenterol (2014) 0.85

An overview on chemical derivatization and stability aspects of selected avermectin derivatives. Chem Pharm Bull (Tokyo) (2012) 0.84

Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil. Int J Pharm (2008) 0.84

Osmotic pumps in drug delivery. Crit Rev Ther Drug Carrier Syst (2004) 0.83

Long QT syndrome manifesting as pulseless epilepsy. Indian J Pediatr (2003) 0.83

High dose vitamin K3 infusion in advanced hepatocellular carcinoma. J Gastroenterol Hepatol (2006) 0.83

Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells. Pharm Res (2012) 0.83

Latent celiac disease in reproductive performance of women. Fertil Steril (2010) 0.82

Electrically switchable polypyrrole film for the tunable release of progesterone. Ther Deliv (2013) 0.81

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol (2008) 0.81

Evaluation of mucoadhesive coatings of chitosan and thiolated chitosan for the colonic delivery of microencapsulated probiotic bacteria. J Microencapsul (2012) 0.81

Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. J Drug Target (2010) 0.80

Cytoview: development of a cell modelling framework. J Biosci (2007) 0.80

Unusual cause of massive upper gastrointestinal bleeding: a pancreatic arteriovenous malformation. JOP (2013) 0.80

Development and evaluation of PIK75 nanosuspension, a phosphatidylinositol-3-kinase inhibitor. Eur J Pharm Sci (2012) 0.80

Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy. Int J Pharm (2013) 0.80

Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm (2009) 0.80

A stability indicating HPLC method for the determination of electrochemically controlled release of risperidone. J Chromatogr Sci (2011) 0.80

High surface area polypyrrole scaffolds for tunable drug delivery. Int J Pharm (2013) 0.80

Comparison of alert verbal painful unresponsiveness scale and the Glasgow Coma Score. Indian Pediatr (2011) 0.80

CancerLectinDB: a database of lectins relevant to cancer. Glycoconj J (2007) 0.79

Balloon sweep in portal biliopathy. Gastrointest Endosc (2010) 0.79

Endoscopic management of multiple duodenal diaphragms: case report. Gastrointest Endosc (2003) 0.79

Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR. Anal Bioanal Chem (2012) 0.79

Progress in remediation of groundwater at petroleum sites in California. Ground Water (2013) 0.78

Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies. Int J Pharm (2011) 0.78

Validation of CRIB II for prediction of mortality in premature babies. Indian Pediatr (2009) 0.78

A modified approach to predict dissolution and absorption of polydisperse powders. Pharm Res (2008) 0.78

Budd-Chiari syndrome. Trop Gastroenterol (2003) 0.78

The clinical risk index of babies (CRIB) score in India. Indian J Pediatr (2002) 0.78

Tracheal agenesis: two case reports. Int J Pediatr Otorhinolaryngol (2005) 0.78

A validated high performance liquid chromatographic method for analysis of isosorbide mononitrate in bulk material and extended release formulations. J Pharm Biomed Anal (2002) 0.77

Properties and mutation studies of a bacteriophage-derived chimeric recombinant staphylolytic protein P128: Comparison to recombinant lysostaphin. Bacteriophage (2013) 0.77

Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis. Saudi J Gastroenterol (2013) 0.77

Development of solid dispersion systems of dapivirine to enhance its solubility. Curr Drug Deliv (2013) 0.76

Low eosinophil count predicts in-hospital mortality in cirrhosis with systemic inflammatory response syndrome. Eur J Gastroenterol Hepatol (2013) 0.76

New Zealand's drug development industry. Int J Environ Res Public Health (2013) 0.75

Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study. Saudi J Gastroenterol (2014) 0.75

Determination of blood glucose concentration by using wavelet transform and neural networks. Iran J Med Sci (2013) 0.75

Iatrogenic hypervitaminosis D as an unusual cause of persistent vomiting: a case report. J Med Case Rep (2014) 0.75

Analytical profile of moxidectin. Profiles Drug Subst Excip Relat Methodol (2013) 0.75

Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int J Nanomedicine (2013) 0.75

Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy. Liver Int (2008) 0.75

Non-vascular drug eluting stents as localized controlled drug delivery platform: preclinical and clinical experience. J Control Release (2013) 0.75

Ultra-small AgNPs impregnated biocompatible hydrogel with highly effective biofilm elimination properties. ACS Appl Mater Interfaces (2020) 0.75

Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR. J Pharm Biomed Anal (2012) 0.75

Low-dose fluoride in postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab (2013) 0.75

Partial recanalisation of hepatic veins in Budd-Chiari syndrome: a case report. Trop Gastroenterol (2005) 0.75

Flow cytometric assessment of the protectants for enhanced in vitro survival of probiotic lactic acid bacteria through simulated human gastro-intestinal stresses. Appl Microbiol Biotechnol (2012) 0.75

Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation. Burns (2011) 0.75

Reversible cholestatic hepatitis due to carbamazepine in an adolescent. Indian J Gastroenterol (2005) 0.75

The effect of immobilization of probiotic Lactobacillus reuteri DPC16 in sub-100 μm microcapsule on food-borne pathogens. World J Microbiol Biotechnol (2012) 0.75

Development and Evaluation of a Topical Anti-Inflammatory Preparation Containing Dodonaea polyandra Extract. J Pharm Pharm Sci (2015) 0.75

Observational sickness assessment by the NICU staff nurses. Indian J Pediatr (2007) 0.75